Atossa Therapeutics
ATOS
$1.46
Share price
-2.01%
Change (1 day)
105.63%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $3.44 M
According to Atossa Therapeutics's latest financial reports the company's total liabilities are $3.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $5.56 M | 78.12% |
| 2021-12-31 | $3.12 M | -80.05% |
| 2020-12-31 | $15.67 M | 1074.87% |
| 2019-12-31 | $1.33 M | -54.25% |
| 2018-12-31 | $2.91 M | 137.92% |
| 2017-12-31 | $1.22 M | 17.01% |
| 2016-12-31 | $1.04 M | -58.14% |
| 2015-12-31 | $2.5 M | 10.4% |
| 2014-12-31 | $2.26 M | 61% |
| 2013-12-31 | $1.4 M | -14.73% |
| 2012-12-31 | $1.65 M | 9.15% |
| 2011-12-31 | $1.51 M | 74.44% |
| 2010-12-31 | $0.86 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 2,960,004.53% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $7.40 B | 214,998.72% | 🇺🇸 USA |
 LabCorp LH | $8.55 B | 248,337.86% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.71 B | 20,716.75% | 🇺🇸 USA |
 Enzo Biochem ENZ | $28.3 M | 721.78% | 🇺🇸 USA |